Sirolimus is more likely to cause ____________ more than cyclosporine:
**Core Concept**
Sirolimus, also known as rapamycin, is a macrolide compound that functions as an immunosuppressant by inhibiting the mammalian target of rapamycin (mTOR) pathway. This pathway is crucial for cell proliferation, growth, and survival. Sirolimus is commonly used in organ transplantation to prevent rejection.
**Why the Correct Answer is Right**
Sirolimus is more likely to cause hyperlipidemia compared to cyclosporine due to its effect on the mTOR pathway. Activation of the mTOR pathway is involved in regulating lipid metabolism, and its inhibition by sirolimus leads to increased levels of triglycerides and cholesterol. This is in contrast to cyclosporine, which primarily causes nephrotoxicity and hypertension as its main side effects. The mTOR pathway also plays a role in regulating insulin sensitivity, and sirolimus can induce insulin resistance, further contributing to hyperlipidemia.
**Why Each Wrong Option is Incorrect**
**Option A:** Nephrotoxicity - This is a common side effect of cyclosporine, not sirolimus.
**Option B:** Hypertension - While both drugs can cause hypertension, it is not a distinguishing feature that sets sirolimus apart from cyclosporine.
**Option C:** Diarrhea - Sirolimus can cause gastrointestinal side effects, but diarrhea is not a specific side effect that differentiates it from cyclosporine.
**Clinical Pearl / High-Yield Fact**
Sirolimus is often used in combination with other immunosuppressants to prevent organ rejection, and its unique side effect profile, including hyperlipidemia, should be considered when choosing an immunosuppressive regimen.
**Correct Answer: B. Hypertension.**